Regen BioPharma Inc (RGBP)

[cvinvestor]

Another way to look at it is: who do you think will carry more leverage and credibility to the table for negotiations, Koos and Cavens or OCP?

Who do you think will get more value on the dollar?

If the answer is OCP should get a higher value by at least 5% overall, then they've already paid for their services and we lose nothing in the deal.

Personally, I'd rather have someone else at this point. Cavens and Koos just gave themselves 10 million preferred shares each for the FDA approval of HemaX after 3 years of getting to an approval and having given themselves tons of shares or buying of shares at 60-80% discounts. Do you think they are going to negotiate at this point in light of shareholder value?